O’Melveny has advised Jiangxi Institute of Biological Products Inc. in connection with its listing on the Main Board of The Hong Kong Stock Exchange. Jiangxi Institute...
Jiangxi Institute of Biological Products Lists on Hong Kong Stock Exchange
TransThera Sciences Completes Placement of New H Shares Raising HK$152 Million
O’Melveny & Myers has advised TransThera Sciences (Nanjing), Inc. TransThera Sciences (Nanjing), Inc. has successfully placed 3,836,000 new H shares under a general mandate at a...
TenNor Therapeutics Raises HK$627 Million in Hong Kong Stock Exchange IPO
Clifford Chance has advised CITIC Securities (Hong Kong) Limited and ABCI Securities Company Limited as joint sponsors. O’Melveny has represented TenNor Therapeutics (Suzhou) Limited. TenNor Therapeutics...
Time Interconnect Technology Raises HK$2.9 Billion Through Share Placement
O’Melveny has represented Macquarie Capital Limited, as overall coordinator, sole placing agent, and sole capital market intermediary. Time Interconnect Technology Limited has successfully conducted a share...
Metis TechBio Completes HK$2.1 Billion IPO on Hong Kong Stock Exchange
O’Melveny has advised the joint sponsors, overall coordinators and other underwriters. Metis TechBio Co., Ltd. has successfully completed its initial public offering and debut listing on...
Cofoe Medical Completes HK$1.062 Billion Listing on the Hong Kong Stock Exchange
O’Melveny & Myers has advised Cofoe Medical Technology Co., Ltd. on its Hong Kong Stock Exchange listing. Cofoe Medical Technology Co., Ltd. has completed its listing...
Diagens Completes HK$790 Million Initial Public Offering on Hong Kong Stock Exchange
O’Melveny has advised Hangzhou Diagens Biotechnology Co., Ltd. in its initial public offering and listing on the Main Board of the Hong Kong Stock Exchange. Hangzhou...
Tiantu Capital Sells Yoplait China Stake for RMB1.8 Billion
O’Melveny & Myers has advised Tian Tu Capital Co., Ltd. on the sale of its interest in Yoplait Dairy Co., Ltd. and on related Hong Kong...
Time Interconnect Technology Completes HK$1.64 Billion Share Placement
O’Melveny & Myers has advised Macquarie in its role as overall coordinator, sole placing agent, and sole capital market intermediary for Time Interconnect Technology Limited. Time...
Shenzhen Woer Heat-Shrinkable Material Lists on Hong Kong Stock Exchange in HK$2.84 Billion Offering
O’Melveny & Myers LLP has advised Shenzhen Woer Heat-Shrinkable Material Co., Ltd. on its listing on the Main Board of the Hong Kong Stock Exchange. Shenzhen...
Distinct Healthcare Holdings Completes HK$285 Million IPO and Hong Kong Listing
O’Melveny & Myers LLP has advised Distinct Healthcare Holdings Limited on its initial public offering and listing. Distinct Healthcare Holdings Limited has completed its initial public...
REFIRE Raises HK$264.81 Million Through H Share Placement
O’Melveny & Myers has advised Shanghai REFIRE Group Limited in its placing of new H shares. Shanghai REFIRE Group Limited has completed the placing of 4,536,000...